- Home
- RMR vs IMMP Comparison
RMR vs IMMP Comparison
Compare RMR & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMR
- IMMP
- Stock Information
- Founded
- RMR 1986
- IMMP 1987
- Country
- RMR United States
- IMMP Australia
- Employees
- RMR N/A
- IMMP N/A
- Industry
- RMR Professional Services
- IMMP Biotechnology: Pharmaceutical Preparations
- Sector
- RMR Consumer Discretionary
- IMMP Health Care
- Exchange
- RMR Nasdaq
- IMMP Nasdaq
- Market Cap
- RMR 250.3M
- IMMP 211.1M
- IPO Year
- RMR N/A
- IMMP N/A
- Fundamental
- Price
- RMR $14.37
- IMMP $1.85
- Analyst Decision
- RMR Strong Buy
- IMMP Buy
- Analyst Count
- RMR 1
- IMMP 2
- Target Price
- RMR $32.00
- IMMP $8.50
- AVG Volume (30 Days)
- RMR 148.0K
- IMMP 645.2K
- Earning Date
- RMR 05-06-2025
- IMMP 05-16-2025
- Dividend Yield
- RMR 12.60%
- IMMP N/A
- EPS Growth
- RMR N/A
- IMMP N/A
- EPS
- RMR 1.06
- IMMP N/A
- Revenue
- RMR $197,672,000.00
- IMMP $3,019,249.00
- Revenue This Year
- RMR $335.64
- IMMP $11.25
- Revenue Next Year
- RMR $1.07
- IMMP $10.22
- P/E Ratio
- RMR $13.44
- IMMP N/A
- Revenue Growth
- RMR N/A
- IMMP 24.11
- 52 Week Low
- RMR $13.48
- IMMP $1.32
- 52 Week High
- RMR $26.43
- IMMP $3.34
- Technical
- Relative Strength Index (RSI)
- RMR 36.28
- IMMP 53.09
- Support Level
- RMR $13.48
- IMMP $1.44
- Resistance Level
- RMR $14.62
- IMMP $2.71
- Average True Range (ATR)
- RMR 0.37
- IMMP 0.18
- MACD
- RMR 0.04
- IMMP 0.03
- Stochastic Oscillator
- RMR 59.42
- IMMP 28.93
About RMR The RMR Group Inc.
The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.